Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease

By Calderón-Salinas J.   Muñoz-Reyes E.   Guerrero-Romero J.   Rodríguez-Morán M.   Bracho-Riquelme R.   Carrera-Gracia M.   Quintanar-Escorza M.  

Molecular and Cellular Biochemistry, Vol. 357, Iss. 1-2, 2011-11 ,pp. : 171-179

Springer Publishing Company

Access to resources Recommend Favorite

Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patients

By Morena Marion   Patrier Laure   Jaussent Isabelle   Bargnoux Anne-Sophie   Dupuy Anne-Marie   Badiou Stééphanie   Leray-Moragues Héélèène   Klouche Kada   Canaud Bernard   Cristol Jean-Paul  

Free Radical Research, Vol. 45, Iss. 6, 2011-06 ,pp. : 735-745

Informa Healthcare

Access to resources Recommend Favorite

Changes of urinary phospholipids in the chronic kidney disease patients

By Yang Wen-Ling   Bai Qiong   Li Dan-Dan   A Ta-La   Wang Song   Zhao Rong-Sheng   Nie Hong-Gang   Zhang Ai-Hua   Wang Tao   Fan Min-Hua  

Biomarkers, Vol. 18, Iss. 7, 2013-11 ,pp. : 601-606

Informa Healthcare

Access to resources Recommend Favorite

Characterization of soluble thrombomodulin levels in patients with stage 3–5 chronic kidney disease

By Bao Yu-Shi   Jia Xi-Bei   Wang Dong   Liu Rui-Chan   Zou Chun-Bo   Na Shi-Ping  

Biomarkers, Vol. 19, Iss. 4, 2014-06 ,pp. : 275-280

Informa Healthcare

Access to resources Recommend Favorite

ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin–angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients

By Zhang Xiao-yan   Ding Xiao-qiang   Lv Wen-lv   Teng Jie   Zhong Yi-hong  

Molecular Biology Reports, Vol. 40, Iss. 10, 2013-10 ,pp. : 5817-5824

Springer Publishing Company

Access to resources Recommend Favorite